EP1277039A1 - Method for the long-term stable and well-reproducible spectrometric measurement of the concentrations of components of aqueous solutions, and device for carrying out said method - Google Patents
Method for the long-term stable and well-reproducible spectrometric measurement of the concentrations of components of aqueous solutions, and device for carrying out said methodInfo
- Publication number
- EP1277039A1 EP1277039A1 EP01940355A EP01940355A EP1277039A1 EP 1277039 A1 EP1277039 A1 EP 1277039A1 EP 01940355 A EP01940355 A EP 01940355A EP 01940355 A EP01940355 A EP 01940355A EP 1277039 A1 EP1277039 A1 EP 1277039A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- measuring
- signal
- measured
- cuvette
- partial
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
- A61B5/1459—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters invasive, e.g. introduced into the body by a catheter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
Definitions
- the invention relates to a method with the features of claim 1 and a device for carrying out this method with the features of claim 6.
- a preferred area of use is the measurement of the glucose concentration in the interstitial body fluid using a device according to the invention in a miniaturized design.
- glucose glucose
- diabetes mellitus the common disease diabetes mellitus
- the average glucose content in the blood of the sufferers is usually significantly increased because these patients have an absolute or relative deficiency Insulin lowers the level of glucose in the blood by, among other things, promoting its absorption into the body cells.
- a cuvette of layer thickness d which is filled with the solution of an absorbing substance of concentration c, is penetrated by a light beam.
- the ratio of the intensity of the light beam leaving the cuvette with light-absorbing substance in the cuvette (l (d)) to the corresponding value without this (lo) is the transmission T, which can be calculated in accordance with the LAMBERT-BEER law.
- the proportionality factor ⁇ is the substance-specific absorption coefficient.
- the object of the present invention is to provide a highly sensitive, simple and reproducible spectrometry method and corresponding devices for the quantitative determination, in particular, of glucose in interstitial body fluids - specifically in the context of an implantable detector.
- the method and device can also be used for other uses, for example for monitoring and controlling chemical processes.
- the selected device should therefore be constructed as simply as possible, ie without moving parts and in particular be miniaturized.
- the device must also contain the power of a large and low-noise opto-electronic gain in order to achieve the required sensitivity and accuracy.
- the measurement should be largely independent of the temperature of the substance to be examined, since these influences can be found directly in the measurement signal. So far, none of the above-mentioned patents has become the basis for a well-known marketable technical development. The methods and devices described in the patents do not seem to be able to meet the requirements mentioned, even for an ex vivo measurement.
- the object of the teaching according to the invention is to combine measuring arrangements known in principle or in parts in a manner that is not obviously suitable and to improve them considerably in terms of measuring accuracy, the problems mentioned being solved in a technically effective and simple manner and the requirements mentioned for a detector for glucose for measurement in body fluids should be met.
- the task is solved according to the requirements.
- a dialysate of the tissue fluid which is freshly brought into equilibrium, is continuously fed to a measuring chamber with the aid of microdialysis.
- the design of the measuring method according to the invention comprises the following characteristics:
- the modulated, quasi monochromatic electromagnetic beams emanating from radiation sources are divided into two partial beams by a suitable beam splitter and their intensities are detected by detectors (e.g. photodiodes) which are largely independent of the wavelength in a certain wavelength band.
- Their output signals photo currents
- Such a difference or quotient formation eliminates intensity fluctuations in the source radiation (s).
- the difference or quotient signals are also modulated, which enables the additional use of the known “lock-in” amplifier technology. This further increases the Sensitivity possible by a factor of up to 10 3 compared to "conventional" electronic amplifier mechanisms.
- the core of the spectrometric measuring method according to the invention and the device used therefor is shown in FIG.
- the essential elements are a beam splitter (2), which divides the beam generated by a radiation source or sources (1) into two beams (measuring and reference beam), a sample cell (3) and a reference cell (4), each in the beam direction behind the beam splitter , as well as two detectors (5 and 6), each of which detects a partial beam behind a cuvette and converts its intensity into electrical signals. These are then processed as required in signal processing.
- Figure 2 shows an embodiment of the measuring arrangement according to the invention.
- the time-dependent intensity (l (t)) of the (practically) monochromatic source radiation from the radiation source (1, e.g. a laser diode) is modulated sinusoidally:
- the intensity-splitting ratio of the beam splitter (2) is chosen such that the two intensities l ⁇ w (t) and lR (t) striking the detectors (5 and 6), while there is no substance (analyte) to be detected in the sample cuvette (3), have the same value, this is the so-called balanced state.
- the two subsequent current-voltage converters (7 and 8) transform the photo currents generated by the detectors into voltages (Uw ⁇ (t) and UR (t)) and at the same time separate the DC voltage component.
- the two following multipliers (9 and 10) with gains n and - n are to be regarded as one of the essential features of this device.
- One of the two multipliers inverts the signal, the second is used for analog compensation of signal propagation times that may occur in the first signal inverter - it doesn't matter which of the two has the gain n or - n.
- the two output voltages of the multipliers are used as supply voltages for a WHEATSTONE measuring bridge or as supply voltages for a voltage divider measuring circuit - this is another important feature of the device according to the invention.
- the bridge voltage is during the analysis
- A is the ratio between the values of U (.) During the analysis (at the respective concentration of the analyte) and the balanced state.
- the bridge voltage can be changed by changing the source intensity of the radiation source; it is (its amount) independent of the position of the sample or reference cuvette, both are interchangeable.
- the bridge voltage caused by the analyte is detected by a "lock-in” amplifier (13), the output signal (a direct voltage UGI) of which is passed on to a measured value processing unit (14), which in the simplest case consists of a visual display device
- the output signal of the "Lock-in” amplifier applies:
- v is the signal amplification of the "Lock-In" amplifier.
- the sensitivity of the end signal of the entire measuring arrangement is the first derivative of this function according to the quantity A, which is dependent on the concentration of the analyte.
- the sensitivity can be adjusted on the one hand by increasing the source intensity and on the other hand by varying the amplification factors n and v. It is only limited by the signal-to-noise ratio of the signal processing and, in particular, is independent of changes in intensity caused by absorption.
- the advantage achieved by the measuring arrangement according to the invention lies in the simple and symmetrical structure, which (largely) eliminates both intensity fluctuations in the source radiation and also changes in absorption due to temperature changes in the measured material.
- it enables the use of “lock-in” amplifier technology, the well-known advantages of which can be used, ie the detection of very small signal changes with simultaneous elimination of external (electrical or optical) disturbance variables which act on the measuring and / or reference path ,
- FIG. 3 shows a preferred extended configuration of the measuring arrangement according to the invention as a two-wavelength spectrometer.
- the two quasi-monochromatic source radiation of the radiation sources (1a and 1b, e.g. laser diodes) have different wavelengths.
- the two initial intensities then have the following time profile:
- the two beams are combined into one beam with the total intensity I, e.g. by coupling the individual beams into the two inputs of a "Y" light guide cable (1c) with a statistical distribution of the light guide fibers.
- the combined beams then leave the common exit of the light guide, the intensities add up. If the two amplitudes of the intensity summands ( lo, ⁇ and lo, 2) the same, the light intensity (l (t)) at the output of the light guide is constant.
- the substance to be detected is continuously and unchangeably present in a concentration that is similar to the expected concentration in the sample.
- the division ratio (IM / IR) of the radiation intensities at the beam splitter (2) is selected so that in the balanced state, ie with the material to be measured without the substance to be detected inside the sample cell (3) (that is, with different analyte contents in the reference and the measuring cuvette) still hits the same intensity on the detectors (5 and 6).
- the intensities are detected by the detectors, whose photocurrents are transformed into voltages by two current-voltage converters (7 and 8) and at the same time the DC voltage components are separated.
- the subsequent multipliers (9 and 10) with the gains n and - n amplify these voltages, so that the voltages Uw ⁇ (t) and UR (t) are present at the outputs of the multipliers.
- the two output voltages (U ⁇ v ⁇ (t) and UR (Q) are used as bridge supply voltages for a WHEATSTONE measuring bridge or as supply voltages for a measuring voltage divider circuit.
- the bridge voltage (Ußr) between the two resistors (11 and 12) and the zero Potential of the circuit is zero, during the analysis (ie the analyte is in a certain concentration in the measuring cuvette) a non-zero bridge voltage is set in.
- the intensity (IR (t)) that hits the detector remains constant in the reference path.
- the bridge voltage during the analysis results according to:
- a and B are the conversion factors for the two wavelengths between the values of Uw ⁇ (t) in the analysis (at the respective concentrations of the analyte) and Uw ⁇ (t) in the balanced state.
- the structure is symmetrical, sample cuvette (3) and reference cuvette (4) and thus the measuring and reference sections of the detector are interchangeable.
- the bridge voltage caused by the analyte is detected by a "lock-in” amplifier (13) and its output signal UGI is passed on to a measured value processing unit (14). The following applies:
- UGI (2 / ⁇ ) ⁇ A • (1 - x) • n • v • Uo v is the signal gain of the "Lock-In" amplifier.
- the sensitivity of the output signal of the entire measuring arrangement is the first derivative of this function according to the quantity A, which depends on the concentration of the analytes:
- FIG. 4 shows a modification of the measuring arrangement shown in FIG. 3.
- an electronic ratio generator (15) can also be used.
- the output voltages of the two current-voltage converters (7 and 8) serve as input signals of the ratio generator.
- the DC voltage components are not separated. The following results for the output voltage of the ratio generator (U (t)):
- v is the signal amplification of the "Lock-In" amplifier.
- the sensitivity of the output signal of the entire measuring arrangement is the first derivative of this function according to the quantity A, which is dependent on the concentration of the analyte:
- FIG. 5 and FIG. 6 show an expansion of the measuring arrangements described with reference to FIGS. 3 and 4.
- the intensities of the individual radiation sources can be superimposed, for example, by multi-arm light guides (FIG. 5) or by dielectric beam splitters (FIG. 6).
- the temporal phase shift of the individual source intensities for three sources is 2- ⁇ / 3 (120 °), for four sources ⁇ / 2 (90 °) and generally for k radiation sources accordingly (2- ⁇ / k, k e N).
- the transfer of the solution form shown in FIGS. 3 and 4 to design using several sources is within the knowledge of the person skilled in the art.
- FIG. This shows the diagram of an arrangement of components according to the device shown in FIG. 3.
- the radiation sources (1 a) were a laser diode ("FNLD 1450", LASER GRAPHICS, Kleinostheim) with a wavelength of 1450 nm and an optical output power of max. 4 mW and (1b) an LED ("LED 16", LASER GRAPHICS, Kleinostheim) with a wavelength of 1580 (+ 150) nm and an optical output power of max. 1, 2 mW.
- Both radiation sources were supplied by current sources (19 and 20: “Model LDC 220”, PROFILE, Karlsfeld), the output currents of which were provided by two function generators (21 and 22: “HM 8131-2", HAMEG, Frankfurt am Main) sinusoidal shape.
- the radiations from the LED and the laser diode were each in one leg of a "Y" -shaped Optical fiber (1 c; a special design with a diameter of 1 mm, LOT-ORIEL, Darmstadt) made of quartz fibers that are permeable to infrared radiation, and the combined beam, which leaves the common end of the optical fiber, from a subsequent collimator lens (18: “DIV-THR -Optik-LWL ", LASER 2000, Wessling) bundled and focused.
- a collimator lens 18: “DIV-THR -Optik-LWL ", LASER 2000, Wessling
- the subsequent beam splitter prism (2:" 44-3861 “, COHERENT, Dieburg) divided the beam into two equally powerful partial beams that separated the following cuvettes (3 and 4; special designs with a layer thickness of 1 mm and a volume of 50 ⁇ L, HELLMA, Müllheim).
- Two InGaAs PIN photodiodes (“G 5832-01", HAMAMATSU, Herrsching) served as detectors (5 and 6), downstream power amplifiers (7 and 8: "DLPCA-100", FEMTO, Berlin) amplified their photo currents.
- the output signals of the current amplifiers were amplified by subsequent voltage amplifiers (9 and 10 "4-channel INH amplifiers", SCIENCE PRODUCTS, Hofheim) and their output voltages at two resistors (11 and 12: “metal layer 1, 2 M ⁇ ", RS, Mörfelden -Walldorf).
- a "lock-in” amplifier 13: "LIA-MV-150", FEMTO, Berlin) and the output signal showed the voltage between the two resistors against circuit zero and its output signal was shown by a digital storage oscilloscope (14: "9304" , LECROY, Heidelberg).
- FIG. 7 shows very precise measurement results even for material to be measured with a low concentration of the substance to be analyzed.
- FIG. 8 shows a calibration curve for D (+) glucose created with this device. For a concentration of 100 mg / dL in the area of the calibration curve, the measurement results in an absolute error of approximately 5 mg / dL.
Abstract
Description
Claims
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10020615A DE10020615C2 (en) | 2000-04-27 | 2000-04-27 | Process for the long-term stable and reproducible spectrometric measurement of the concentrations of the components of aqueous solutions and device for carrying out this process |
DE10020615 | 2000-04-27 | ||
PCT/EP2001/004587 WO2001084123A1 (en) | 2000-04-27 | 2001-04-24 | Method for the long-term stable and well-reproducible spectrometric measurement of the concentrations of components of aqueous solutions, and device for carrying out said method |
Publications (1)
Publication Number | Publication Date |
---|---|
EP1277039A1 true EP1277039A1 (en) | 2003-01-22 |
Family
ID=7640087
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP01940355A Withdrawn EP1277039A1 (en) | 2000-04-27 | 2001-04-24 | Method for the long-term stable and well-reproducible spectrometric measurement of the concentrations of components of aqueous solutions, and device for carrying out said method |
Country Status (5)
Country | Link |
---|---|
US (1) | US20030147078A1 (en) |
EP (1) | EP1277039A1 (en) |
AU (1) | AU7396101A (en) |
DE (1) | DE10020615C2 (en) |
WO (1) | WO2001084123A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10316685A1 (en) | 2003-04-10 | 2004-10-28 | Endress + Hauser Conducta Gesellschaft für Mess- und Regeltechnik mbH + Co. KG | Device for the photometric measurement of the concentration of a chemical substance in a measuring solution |
US7307718B2 (en) * | 2004-02-23 | 2007-12-11 | Ortho-Clinical Diagnostics, Inc. | Determining an analyte by multiple measurements through a cuvette |
US20050185176A1 (en) * | 2004-02-23 | 2005-08-25 | Moran Donald J.Jr. | Determining an analyte by multiple measurements through a cuvette |
US20080281298A1 (en) * | 2005-02-07 | 2008-11-13 | Andersen David R | Electronic support system for biological data sensor |
DE102007032849A1 (en) * | 2007-03-16 | 2008-09-18 | Biocomfort Diagnostics Gmbh | Measuring device and method for optical concentration determination of blood sugar and / or lactate in biological systems |
DE102010034626A1 (en) * | 2010-08-17 | 2012-02-23 | B. Braun Avitum Ag | Device for extracorporeal blood treatment |
US10335075B2 (en) | 2013-03-14 | 2019-07-02 | Dexcom, Inc. | Advanced calibration for analyte sensors |
Family Cites Families (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3680957A (en) * | 1967-10-10 | 1972-08-01 | Shimadzu Corp | Automatic spectrophotometer |
US3697185A (en) * | 1970-08-06 | 1972-10-10 | Technicon Instr | Method and apparatus for the time sharing of multiple channel analysis means |
US3807875A (en) * | 1971-06-09 | 1974-04-30 | Corning Glass Works | Densitometry apparatus |
CH569972A5 (en) * | 1974-07-16 | 1975-11-28 | Cerberus Ag | |
US3994597A (en) * | 1974-12-26 | 1976-11-30 | Calder William E | Optical sight with variable illumination |
DE2734560A1 (en) * | 1977-07-30 | 1979-02-22 | Bals Hans G Dipl Ing | BICYCLE-LIKE TWO-WHEEL VEHICLE |
US4371785A (en) * | 1980-08-14 | 1983-02-01 | Panametrics, Inc. | Method and apparatus for detection and analysis of fluids |
US4410273A (en) * | 1981-03-09 | 1983-10-18 | Laser Analytics, Inc. | Scanning laser spectrometer |
US4762413A (en) * | 1984-09-07 | 1988-08-09 | Olympus Optical Co., Ltd. | Method and apparatus for measuring immunological reaction with the aid of fluctuation in intensity of scattered light |
DE3510052A1 (en) * | 1985-03-20 | 1986-09-25 | Kernforschungszentrum Karlsruhe Gmbh, 7500 Karlsruhe | METHOD AND PROCESS PHOTOMETER FOR CONTINUOUS MEASUREMENT OF CONCENTRATIONS |
DE3633931A1 (en) * | 1986-10-04 | 1988-04-07 | Kernforschungsz Karlsruhe | METHOD AND DEVICE FOR CONTINUOUSLY MEASURING THE CONCENTRATION OF A GAS COMPONENT |
US4849636A (en) * | 1988-05-18 | 1989-07-18 | Mine Safety Appliances Company | Analyzer with compensation |
US5222496A (en) * | 1990-02-02 | 1993-06-29 | Angiomedics Ii, Inc. | Infrared glucose sensor |
US5222495A (en) * | 1990-02-02 | 1993-06-29 | Angiomedics Ii, Inc. | Non-invasive blood analysis by near infrared absorption measurements using two closely spaced wavelengths |
US5149983A (en) * | 1990-09-07 | 1992-09-22 | Chlean Plants & Engineering Establishment | Method and apparatus for measuring the concentration of at least one material in a fluid medium mixed materials |
US5243983A (en) * | 1990-12-14 | 1993-09-14 | Georgia Tech Research Corporation | Non-invasive blood glucose measurement system and method using stimulated raman spectroscopy |
US6351309B1 (en) * | 1991-08-06 | 2002-02-26 | Southwest Sciences Incorporated | Dual modulation laser line-locking technique for wavelength modulation spectroscopy |
WO1993012712A1 (en) * | 1991-12-31 | 1993-07-08 | Vivascan Corporation | Blood constituent determination based on differential spectral analysis |
US5434412A (en) * | 1992-07-15 | 1995-07-18 | Myron J. Block | Non-spectrophotometric measurement of analyte concentrations and optical properties of objects |
US5672875A (en) * | 1992-07-15 | 1997-09-30 | Optix Lp | Methods of minimizing scattering and improving tissue sampling in non-invasive testing and imaging |
US5433197A (en) * | 1992-09-04 | 1995-07-18 | Stark; Edward W. | Non-invasive glucose measurement method and apparatus |
US5398681A (en) * | 1992-12-10 | 1995-03-21 | Sunshine Medical Instruments, Inc. | Pocket-type instrument for non-invasive measurement of blood glucose concentration |
US5381010A (en) * | 1993-12-03 | 1995-01-10 | Sleepair Corporation | Periodically alternating path and alternating wavelength bridges for quantitative and ultrasensitive measurement of vapor concentration |
US5492118A (en) * | 1993-12-16 | 1996-02-20 | Board Of Trustees Of The University Of Illinois | Determining material concentrations in tissues |
TW275570B (en) * | 1994-05-05 | 1996-05-11 | Boehringer Mannheim Gmbh | |
US5572031A (en) * | 1994-11-23 | 1996-11-05 | Sri International | Pressure- and temperature-compensating oxygen sensor |
US5638816A (en) * | 1995-06-07 | 1997-06-17 | Masimo Corporation | Active pulse blood constituent monitoring |
US5743262A (en) * | 1995-06-07 | 1998-04-28 | Masimo Corporation | Blood glucose monitoring system |
JPH10281988A (en) * | 1997-04-09 | 1998-10-23 | Nippon Sanso Kk | Method and device for gas analysis |
US5823966A (en) * | 1997-05-20 | 1998-10-20 | Buchert; Janusz Michal | Non-invasive continuous blood glucose monitoring |
AU4224299A (en) * | 1998-05-29 | 1999-12-13 | Sarnoff Corporation | Diode laser-based breath-compound detection system and method |
DE19826294C1 (en) * | 1998-06-12 | 2000-02-10 | Glukomeditech Ag | Polarimetric method for determining the (main) vibration plane of polarized light at about 0.1 m DEG and miniaturizable device for its implementation |
-
2000
- 2000-04-27 DE DE10020615A patent/DE10020615C2/en not_active Expired - Fee Related
-
2001
- 2001-04-24 AU AU73961/01A patent/AU7396101A/en not_active Abandoned
- 2001-04-24 WO PCT/EP2001/004587 patent/WO2001084123A1/en active Application Filing
- 2001-04-24 US US10/258,175 patent/US20030147078A1/en not_active Abandoned
- 2001-04-24 EP EP01940355A patent/EP1277039A1/en not_active Withdrawn
Non-Patent Citations (2)
Title |
---|
None * |
See also references of WO0184123A1 * |
Also Published As
Publication number | Publication date |
---|---|
US20030147078A1 (en) | 2003-08-07 |
DE10020615C2 (en) | 2002-02-28 |
AU7396101A (en) | 2001-11-12 |
DE10020615A1 (en) | 2001-11-08 |
WO2001084123A1 (en) | 2001-11-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0030610B1 (en) | Method and device for quantitative determination of optically active substances | |
EP0818682B1 (en) | Method and device for the optical measurement of the total hemoglobin concentration | |
EP1130998B1 (en) | Device for non-invasively detecting the oxygen metabolism in tissues | |
DE69737363T2 (en) | MONITORING OF TISSUE INGREDIENTS BY INFRARED RADIATION | |
DE102006036920B3 (en) | Measuring glucose concentration in pulsating blood involves determining concentration in first measurement cycle, repeating, measuring transmission, scattering for near infrared wavelengths, computing indicator value, comparing with table | |
DE19826294C1 (en) | Polarimetric method for determining the (main) vibration plane of polarized light at about 0.1 m DEG and miniaturizable device for its implementation | |
WO1994010901A1 (en) | Process and device for glucose determination in a biological matrix | |
EP2710348B1 (en) | Method and system for determining the concentration of substances in bodily fluids | |
DE2934190A1 (en) | METHOD AND DEVICE FOR MOLECULAR SPECTROSCOPY, ESPECIALLY FOR DETERMINING METABOLISM PRODUCTS | |
WO1995012348A1 (en) | Process and device for determining the glucose concentration in a biological matrix | |
WO1997027469A1 (en) | Process and device for determining an analyte contained in a scattering matrix | |
EP3051271A1 (en) | Method for assaying lipids and other interferents in body fluid samples | |
DE2724543C2 (en) | Use of a polarimetric method for the quantitative determination of blood glucose | |
DE102007031284A1 (en) | Concentration sensor and method of production | |
Bassi et al. | Time-resolved spectrophotometer for turbid media based on supercontinuum generation in a photonic crystal fiber | |
DE10020615C2 (en) | Process for the long-term stable and reproducible spectrometric measurement of the concentrations of the components of aqueous solutions and device for carrying out this process | |
DE4446390C1 (en) | Analyte concn. measuring method, e.g. for medical blood diagnosis | |
DE3541165C2 (en) | ||
AT390145B (en) | METHOD FOR DETERMINING THE CONCENTRATION OF SUBSTANCES, IN PARTICULAR OXYGEN | |
DE19911265C2 (en) | Device for measuring the glucose concentration of protein-containing aqueous solutions, in particular in interstitial tissue fluids, preferably in implantable micro-opto-electronic form | |
DE2927156A1 (en) | DEVICE FOR MEASURING THE OXYGEN CONCENTRATION | |
DE4325529C2 (en) | Device for determining the concentration of substances in the blood | |
EP0679064A1 (en) | Method and device for the non-invasive transcutanean determination of the concentrations of substances in human body fluids or tissues | |
DE10020613C2 (en) | Process for the long-term stable and reproducible polarimetric measurement of the concentrations of the components of aqueous solutions and device for carrying out this process | |
DE3736092A1 (en) | Measuring device for continuously determining the glucose concentration in interstitial liquids |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20021118 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: SANGUIBIOTECH GMBH |
|
17Q | First examination report despatched |
Effective date: 20050504 |
|
17Q | First examination report despatched |
Effective date: 20050504 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20091102 |